Submit ICO / Airdrop ★ Get Promotion
ProjectsDeFiAirdropsSTOsPromotionMarks newsWatchlist ()
0
Banana Bomb

Banana Bomb

ICO Ended
8,717 Views
Visit Website
Last screenshot taken on
21 Mar 2020 .
Add to Watchlist
Banana Bomb is a Deflationary/Reward Token with a Destruction rate of 3.5%. This means the total supply decreases with each transaction. Reward Rate of 3.5%, it means 3.5% of every transaction is sent to a reward wallet. These reward tokens are then distributed to a randomly generated number of users every month.
Cryptocurrency
5.4
TOTAL SCORE
5.4
ICO PROFILE

(weight: 45%)

1
TEAM PROOF

(weight: 20%)

Get widget
General
Website: Visit
White paper: Read
Pre-sale Time: 27 Dec 2019 - 27 Jan 2020
ICO Time: 01 Feb 2020 - 15 Dec 2020
Country: Brazil
Token info
Ticker: B77
Platform: Ethereum
Token Type: ERC-20
Total supply: 250,000,000 B77
Financial
ICO Price: 1 B77 = 2 BTCM
Accepting: SATX, ETH, BTC
Hard cap: 100,000 USD
Bonuses: Round 1: 50% bonus
Round2: 40% bonus
Round 3: 30% bonus
Round 4: 20% bonus
Round 5: 10% bonus
Round 6: 0% bonus
Social media
Facebook
Twitter
Telegram
Screenshots taken on 19 Feb 2020
HORIZONTAL
SQUARE
HEIGHT - 0px
WIDTH - 0px
PUT THIS CODE TO YOUR WEBSITE
ICO List
Other Interesting ICOs
Upcoming
Collectible
Collectible is the exclusive NFT + Physical Item online platform out there. It’s one of a kind. Just like its items. With different unannounced drops happening every week ranging from sport memorabilia to long century old art brought back to life through our NFT creating process making it relevant again. Through our top-notch blockchain technology and NFT creating service we provide a level of authenticity to users that hasn't been seen since the beginning of the internet.
Upcoming
Pharmeum
Pharmeum is the world's first blockchain-based prescription platform with AI health analytics, which is currently working alongside the National Health Service (NHS) in England. The Pharmeum platform is an inter-operable, decentralised, digital prescription platform running over an intelligent neural network. Empowering patients’ ownership of their medication history, and enabling affordable access to healthcare globally. Medical errors and late diagnoses are minimised by using a permissioned blockchain integrated with artificial intelligence. Pharmeum is an advanced, digitised, health eco-system.The Pharmeum blockchain will improve medicine affordability, minimise errors, and create frictionless, quality care for patients.
Upcoming
Potentiam
The founders of Potentiam have worked in music management for a number of years and realise and understand the difficulties involved in promoting new emerging music artists. In 2016 they founded a music publication Britznbeatz to help discover and promote musicians which continues to gain respect and recognition in the industry.
Upcoming
Escrowblock
The aim of the project is to create an EscrowBlock platform for the Ethereum network blockchain. Such a platform can work as an independent environment, or be integrated into other Smart contracts, to provide escrow services as part of any other projects. The team will start the project on Mainnet Ethereum blockchain and then make a fork for providing an independent service.
Upcoming
Data Choice
Take control of your personal data. Your data is used virtually every second you are online, to target you with ads. Data Choice will allow you to take control of what you share, what you keep private, control of the ads you see, and reward you for your data being used.
Pre-Sale
2GETHER
2gether is developing the bank of the future, a future where; consumers take full ownership and control of the services they use, move beyond solely interacting with euros and dollars and fully embrace cryptocurrencies and digital assets, and augment their financial decisions through the use of exponential technologies like artificial intelligence, big data and blockchain. We are on a mission to change the way people interact with their finances. We are building a modern mutual organisation where everyone is an owner of their banking experience.